Skip to search formSkip to main contentSkip to account menu

Patient Derived Xenograft

Known as: Patient-Derived Xenograft, PDX, Patient-Derived Xenograft Model 
The transfer of a tumor fragment from a patient into an immunodeficient mouse.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Aberrant activation of histone lysine-specific demethylase (LSD1) increases tumorigenicity; hence, LSD1 is considered a… 
2017
2017
This study aimed to investigate the feasibility of the establishment of a human cancer xenograft model using samples from… 
Review
2016
Review
2016
ABSTRACT Introduction: Cutaneous metastatic melanoma (MM) is an aggressive form of skin cancer, with treatment providing cures to… 
2016
2016
BackgroundKIOM-CRC#BP3B (BP3B) is a novel herbal prescription that is composed of three plant extracts. Our preliminary study… 
2014
2014
The patient-derived tumor xenograft (PDTX) models can reproduce a similar natural genetic background and similar biological… 
2013
2013
BackgroundPreclinical trials of cancer therapeutics require both in vitro and in vivo evaluations. Recently, a patient-derived… 
2013
2013
Recently, the BRAF V600 inhibitor, vemurafenib, has revolutionized the therapeutic management of metastatic melanoma. However… 
1988
1988
Pulsed NMR relaxation-time measurements have been performed on PdT/sub x/, aged approximately eight years, after first removing…